CD5L and chronic obstructive pulmonary disease: The plasma AIM/IgM ratio was significantly higher in smokers with COPD than in healthy smokers, whereas there were no differences between smokers with COPD and nonsmokers or between healthy smokers and nonsmokers (Fig. 6A).